
Covid-19 approval milestone for those who can’t be vaccinated
AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) and is the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in Great Britain. The use of this medicine is for adults who are not currently… Read More















